$NUVB
Nuvation Bio Inc.
XNYS•Health Care•Pharmaceutical Preparations
$4.95
▼-3.70%-$0.190
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is NUVB down today? It is at $4.95 (-3.70%), and our scanner flagged it 113 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NUVB spikes, and full due diligence on NUVB — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NUVB 113 times in the last 30 days. Create a free account to track $NUVB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
NUVB is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 14 unusual-volume and momentum alerts on NUVB today, peaking at 347.3x its normal volume.
Likely catalystNuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business UpdateReported Achieved $31.7 million in second quarter 2026 total revenue, including $23.2 million in net product revenue for IBTROZI® (taletrectinib)Reported ~85% of the approximatelyReported 160 new patients were TKI-naïve, representing QoQ growth of ~30% in this setting, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 21, 2026 · 45 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
About $241.2M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hattersley Gary Officer | Sold (automatic/other) | -100K 0.03% of company | n/a | n/a | $709K at $7.09 | Aug 19, 26 |
Hattersley Gary Officer | Other | 100K 0.03% of company | n/a | 100K | $187K at $1.87 | Aug 19, 26 |
Sauvage Philippe Officer | Other | 40K 0.01% of company | added 100% | 54K | $79K at $1.97 | Jul 15, 26 |
Sauvage Philippe Officer | Sold (automatic/other) | -48K 0.01% of company | sold 79% | 13K | $286K at $6.01 | Jun 23, 26 |
Sauvage Philippe Officer | Other | 48K 0.01% of company | added 100% | 60K | $103K at $2.17 | Jun 23, 26 |
Wentworth Kerry Officer | Sold (automatic/other) | -63K 0.02% of company | sold 54% | 53K | $379K at $6.02 | Jun 23, 26 |
Wentworth Kerry Officer | Other | 63K 0.02% of company | added 100% | 116K | $185K at $2.93 | Jun 23, 26 |
Markel Stacy Officer | Sold (automatic/other) | -125K 0.04% of company | sold 79% | 33K | $754K at $6.03 | Jun 23, 26 |
Markel Stacy Officer | Other | 125K 0.04% of company | added 100% | 158K | $218K at $1.74 | Jun 23, 26 |
Mashal Robert Director | Bought (open market) | +25K | added 13% | 225K | $118K at $4.73 | Jun 9, 26 |
Liu Dongfang Officer | Sold (automatic/other) | -50K 0.01% of company | sold 74% | 18K | $251K at $5.02 | Apr 17, 26 |
Liu Dongfang Officer | Other | 50K 0.01% of company | added 100% | 68K | $97K at $1.94 | Apr 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
NUVB is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 14 unusual-volume and momentum alerts on NUVB today, peaking at 347.3x its normal volume.
NUVB last traded at $4.95, down 3.70% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Nuvation Bio Inc. (NUVB) is next expected to report earnings on Monday, November 2, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The NUVB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NUVB 113 times in the last 30 days.
NUVB (Nuvation Bio Inc.) trades on XNYS, with a market cap of about $1.80B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NUVB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NUVB discussion
Sign in to ask a question or join the discussion.